Aayush Wellness Limited (BOM:539528)
India · Delayed Price · Currency is INR 29.68
+1.41 (4.99%)
At close: Mar 5, 2026
Aayush Wellness Revenue
Aayush Wellness had revenue of 445.31M INR in the quarter ending December 31, 2025, with 73.73% growth. This brings the company's revenue in the last twelve months to 1.29B, up 153.82% year-over-year. In the fiscal year ending March 31, 2025, Aayush Wellness had annual revenue of 733.46M with 12,063.47% growth.
Revenue (ttm)
1.29B
Revenue Growth
+153.82%
P/S Ratio
1.12
Revenue / Employee
184.90M
Employees
7
Market Cap
1.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 733.46M | 727.43M | 12,063.47% |
| Mar 31, 2024 | 6.03M | -74.99M | -92.56% |
| Mar 31, 2023 | 81.02M | -93.56M | -53.59% |
| Mar 31, 2022 | 174.58M | -1.34B | -88.48% |
| Mar 31, 2021 | 1.52B | 242.17M | 19.01% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.40B |
| Bal Pharma | 3.09B |
| Parnax Lab | 2.28B |
| Ambalal Sarabhai Enterprises | 2.03B |
| Lactose (India) | 1.45B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.13B |
| Coral Laboratories | 875.55M |